Health officials at Ndlavela Health Center in Mozambique during the launch of Lenacapavir HIV prevention programme

Mozambique Rolls Out Lenacapavir for HIV Prevention

April 28, 2026 Michael Gwarisa

Michael Gwarisa Mozambique yesterday joined other African countries that have introduced and added Lenacapavir, a long-acting injectable HIV prevention drug, into their biomedical prevention methods. Other countries that have introduced the HIV prevention drug include Eswatini, Kenya, Lesotho, Nigeria, South Africa, Uganda, Zambia, and Zimbabwe. In Mozambique, the official launch was hosted at the

Healthcare worker discussing Lenacapavir HIV prevention injection rollout in Zimbabwe

Features HIV/AIDS

Lenacapavir Doses Now In Zimbabwe, But Experts Urge Caution

February 3, 2026 Michael Gwarisa

Michael Gwarisa As Zimbabwe takes delivery of its first doses of Lenacapavir, the new long-acting injectable for HIV prevention, public health experts are urging citizens to understand that this is not a replacement for existing prevention methods, but rather a powerful addition to the country’s combination prevention approach. The announcement came during a Continuing Medical